Updated:
VP Venture Partners
VP Venture Partners is a private venture capital firm founded in 2020 in Zurich, Switzerland.
VP Venture Partners
VP Venture Partners is a private venture capital firm founded in 2020 in Zurich, Switzerland. It invests in early-stage life science companies in Europe, focusing on pre-seed or seed stage ventures in medical devices, digital health, and diagnostics. The firm targets areas of unmet need, providing support, coaching, and financing to startups.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Switzerland
City
Zurich
Corporate office
Zurich, Switzerland
Principals
Dr. Valentin Piëch
Founder and Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at VP Venture Partners?
Dr. Valentin Piëch is the Founder and Managing Director. He is a descendant of Ferdinand Porsche and part of the family that controls Porsche SE and Volkswagen Group. Investment decisions appear to flow through him as the central principal, consistent with a single-family-office operating model.
How is VP Venture Partners related to the Porsche/Piëch family industrial holdings?
Valentin Piëch is a member of the Piëch/Porsche family, which controls Porsche SE — the holding company that owns a majority voting stake in Volkswagen Group. VP Venture Partners represents his personal venture investment vehicle, distinct from the family's controlling automotive interests. The wealth origin is the family's multi-generational industrial legacy.
Does VP Venture Partners operate more like a family office or an institutional venture firm?
The firm behaves like a principal investment vehicle with family-office characteristics. It does not appear to actively market to external limited partners or operate a conventional institutional fund structure. The lean, Zurich-based setup and concentration of decision-making with Dr. Piëch point to a single-family deployment platform rather than a third-party asset manager.
How does VP Venture Partners source its deals, and what is its relationship with BioMedPartners?
Dr. Piëch is a Partner at BioMedPartners, a Swiss life-sciences venture firm, and the two entities frequently co-invest. The firm's deal flow is likely sourced through this partnership, Piëch's membership in SECA (the Swiss Private Equity & Corporate Finance Association), and his participation in the EIT Health innovation network. The Swiss and broader European innovation ecosystems form the primary sourcing geography.
Does VP Venture Partners invest only in life sciences?
No. While a dedicated Life Science Investment Portfolio operates under the VP Venture Partners umbrella and Piëch's parallel vehicle impact2partners focuses on rare diseases, the main mandate is described as generalist, with early-stage venture deployment across sectors including enterprise software and digital health.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: